Inventurus Knowledge Solutions Ltd Share Price – NSE /  BSE

IT - Software, Small Cap

IKS Health announced the successful completion of its previously announced acquisition of TruBridge?, Inc. TruBridge is a prominent provider of healthcare technology including an electronic health record (EHR) and revenue cycle management solutions for rural and community hospitals. Following the closing, TruBridge operates as a wholly owned subsidiary of IKS Health.

With nearly one in five Americans facing challenges accessing care, rural and community hospitals are under immediate pressure to alleviate administrative, clinical, and operational burdens. To address these systemic challenges, IKS Health is developing a purpose-built, intelligent healthcare operating system designed to optimize the entire care journey.

The combined organization supports more than 2,000 healthcare organizations and over 150,000 clinicians across the U.S. Customers of all sizes can expect continued, uninterrupted support, and expanded investment in future innovation. Existing products will remain available as standalone offerings to ensure complete continuity of service. By driving financially sustainable, high-quality, and accountable care across the acute and ambulatory continuum, this scalable technology will deliver transformative value across the entire combined client base, regardless of EHR infrastructure.

This acquisition represents a pivotal investment in the rural and community health sector, positioning IKS Health to capture a significant share of a $260 billion total addressable market. By accelerating the deployment of advanced AI capabilities, including specialized large language model (LLM) solutions, IKS Health will enable customers to automate complex workflows and unlock greater value from their clinical data. The transaction is structured to drive long-term shareholder value by broadening customer reach, deepening cross-sell opportunities, and creating a highly scalable business primed for sustainable, profitable growth.

Inventurus Knowledge Solutions has approved the grant of 131,114 stock option to certain eligible employees under the IKS ESOP Plan on 16 June 2026.

Axis Bank Ltd, Alkyl Amines Chemicals Ltd, J B Chemicals & Pharmaceuticals Ltd, Uno Minda Ltd are among the other stocks to see a surge in volumes on BSE today, 14 May 2026.

Inventurus Knowledge Solutions Ltd clocked volume of 1.9 lakh shares by 10:47 IST on BSE, a 14.87 times surge over two-week average daily volume of 12786 shares. The stock gained 0.73% to Rs.1,688.95. Volumes stood at 5835 shares in the last session.

Axis Bank Ltd recorded volume of 65.1 lakh shares by 10:47 IST on BSE, a 11.98 times surge over two-week average daily volume of 5.43 lakh shares. The stock lost 1.14% to Rs.1,241.40. Volumes stood at 4.41 lakh shares in the last session.

Alkyl Amines Chemicals Ltd witnessed volume of 1.15 lakh shares by 10:47 IST on BSE, a 11.89 times surge over two-week average daily volume of 9684 shares. The stock increased 12.52% to Rs.1,838.15. Volumes stood at 3539 shares in the last session.

J B Chemicals & Pharmaceuticals Ltd witnessed volume of 1.56 lakh shares by 10:47 IST on BSE, a 9.35 times surge over two-week average daily volume of 16715 shares. The stock increased 0.77% to Rs.2,111.00. Volumes stood at 14362 shares in the last session.

Uno Minda Ltd saw volume of 2.34 lakh shares by 10:47 IST on BSE, a 6.42 fold spurt over two-week average daily volume of 36380 shares. The stock dropped 1.31% to Rs.1,111.40. Volumes stood at 56905 shares in the last session.

Powered by Capital Market - Live News

Net profit of Inventurus Knowledge Solutions rose 39.36% to Rs 205.97 crore in the quarter ended March 2026 as against Rs 147.80 crore during the previous quarter ended March 2025. Sales rose 18.47% to Rs 857.65 crore in the quarter ended March 2026 as against Rs 723.96 crore during the previous quarter ended March 2025.

For the full year,net profit rose 48.45% to Rs 721.55 crore in the year ended March 2026 as against Rs 486.06 crore during the previous year ended March 2025. Sales rose 19.89% to Rs 3193.79 crore in the year ended March 2026 as against Rs 2663.99 crore during the previous year ended March 2025.

Powered by Capital Market - Live News